Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate ICCC?
The average price target is $0.00.
ICCC Key Metrics
Key financial metrics for ICCC
Metric
Value
Price
$9.88
Market Cap
$89.65M
P/E Ratio
-140.91
EPS
$-0.07
Dividend Yield
0.00%
52-Week High
$10.25
52-Week Low
$3.38
Volume
0
Avg Volume
0
Revenue (TTM)
$29.93M
Net Income
$-545.40K
Gross Margin
42.59%
ICCC Analyst Consensus
ICCC analyst coverage data. Average price target: $0.00.
